Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 8695089 | 3 pages | https://doi.org/10.1155/2019/8695089

Corrigendum to “Spermidine Prevents Heart Injury in Neonatal Rats Exposed to Intrauterine Hypoxia by Inhibiting Oxidative Stress and Mitochondrial Fragmentation”

Received08 Jul 2019
Accepted16 Jul 2019
Published04 Sep 2019

In the article titled “Spermidine Prevents Heart Injury in Neonatal Rats Exposed to Intrauterine Hypoxia by Inhibiting Oxidative Stress and Mitochondrial Fragmentation” [1], the authors made a typographical error in Figure 5(d) during the proofreading stage as an extra PGC-1α was added in the section of the protein name. However, it should be removed. The authors apologize for this error and confirm that it does not affect the conclusions or the results of the article.

The corrected version of Figure 5 is as follows.

References

  1. N. Chai, H. Zhang, L. Li et al., “Spermidine prevents heart injury in neonatal rats exposed to intrauterine hypoxia by inhibiting oxidative stress and mitochondrial fragmentation,” Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 5406468, 14 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2019 Nannan Chai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

380 Views | 164 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.